Table 2.

Geometric Mean Concentrations^* (nmol/mL) of Carotenoids and Retinol by Extent of Prostate Biopsy Cores Inflamed in 235 Men without Prostate Cancer and Irrespective of Indication for Biopsy^**, Placebo Arm, PCPT

	None	95%CI	Any	95%CI	Some	95%CI	All	95%CI	p-trend
β-cryptoxanthin	0.15	(0.13,0.097)	0.16	(0.14,0.17)	0.16	(0.15,0.18)	0.15	(0.132,0.17)	0.91
Lycopene	0.63	(0.56,0.17)	0.64	(0.61,0.69)	0.64	(0.59,0.69)	0.66	(0.59,0.74)	0.54
α-carotene	0.088	(0.074,0.11)	0.085	(0.077,0.093)	0.088	(0.079,0.098)	0.078	(0.066,0.092)	0.46
β-carotene	0.46	(0.38,0.55)	0.43	(0.39,0.47)	0.44	(0.39,0.50)	0.41	(0.34,0.48)	0.35
Sum of these carotenoids	1.42	(1.26,1.59)	1.41	(1.31,1.50)	1.41	(1.31,1.53)	1.38	(1.24,1.55)	0.78
Retinol	2.42	(2.27,2.58)	2.34	(2.27,2.43)	2.36	(2.26,2.45)	2.32	(2.19,2.46)	0.18

^*Adjusted for baseline age, race, family history of prostate cancer, serum cholesterol; linear models for P-trend across none, some, all cores inflamed adjusted for baseline age, race, family history of prostate cancer, serum cholesterol, tested at α=0.05 with no cores inflamed as the reference.

^**92.8% did not have a clinical indication for biopsy